Format

Send to

Choose Destination
J Food Drug Anal. 2018 Jan;26(1):1-13. doi: 10.1016/j.jfda.2017.10.010. Epub 2017 Dec 1.

Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea.

Author information

1
Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8020, USA. Electronic address: csyang@pharmacy.rutgers.edu.
2
Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8020, USA.

Abstract

Tea, a popular beverage made from leaves of the plant Camellia sinensis, has been studied extensively in recent decades for its beneficial health effects in the prevention of obesity, metabolic syndrome, diabetes, cancer, and other diseases. Whereas these beneficial effects have been convincingly demonstrated in most laboratory studies, results from human studies have not been consistent. Some studies demonstrated that weight reduction, alleviation of metabolic syndrome and risk reduction in diabetes were only observed in individuals who consume 3-4 cups of tea (600-900 mg tea catechins) or more daily. This chapter reviews some of these studies, the possible mechanisms of actions of tea constituents, and the challenges in extrapolating laboratory studies to human situations.

KEYWORDS:

Cancer; Diabetes; Metabolic syndrome; Obesity; Polyphenols

PMID:
29389543
DOI:
10.1016/j.jfda.2017.10.010
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center